Henrik Nistrup, MD
Medical Director interpreting suPAR, biomarkers, hormones, clinical genetics, and prevention plans at Aetas
At a glance
- Years in practice
- 44
Practice
About
Henrik Nistrup, MD is Medical Director at Aetas Diagnostics and the Danish-registered responsible physician for the Hellerup practice. He has held Danish medical authorization since 1982 and independent-practice permission since 1984. Before Aetas, he spent decades in pharmaceutical and life-sciences leadership, including roles at Novo Nordisk, AstraZeneca across several regions, and Agilent Technologies. At Aetas, he leads clinical interpretation across suPAR inflammation scoring, blood biomarkers, clinical genetics, hormones, and prevention planning.
Approach
Signature approach
Nistrup reads Aetas results as a layered prevention profile: suPAR for chronic inflammation, cardiometabolic markers for metabolic load, hormone markers for endocrine status, and genetics for inherited risk. The goal is to act on drift in repeat panels before inflammation, glucose handling, hormones, or other risk signals become a clinical event.
What sets them apart
- Long Danish medical registry history. He has held medical authorization since 1982 and independent-practice permission since 1984.
- Life-sciences leadership. Novo Nordisk, AstraZeneca, and Agilent roles give him diagnostic-platform experience beyond a conventional clinic career.
- Responsible physician role. He carries the regulatory physician accountability for Aetas's specialist practice.
Focus
Specialties
Who they see
Conditions treated
- Chronic low-grade inflammationSubclinical systemic inflammation (suPAR-guided)
- Hormone imbalance in menTestosterone deficiency / male hypogonadism
- Menopause and perimenopause symptomsMenopausal hormone therapy (HRT)
- Nutritional deficiencies and fatigueMicronutrient insufficiency and metabolic optimization
- Early cancer risk detectionMulti-cancer early detection screening
- Heavy metal and toxin exposureEnvironmental toxicology screening
- Genetic risk for inherited conditionsClinical genetic risk assessment
- Brain health and cognitive decline riskNeurodegeneration biomarker assessment (P-tau, NfL)
Training
Education
- MD, MedicineUniversity of Copenhagen
Protocols
- Supar chronic inflammation testing
- Comprehensive blood biomarker panels (125+ markers)
- Hormone replacement therapy (hrt/trt)
- Clinical genetics panels (iso 15189 / cap certified)
- Toxdetect environmental screening (27 chemicals/heavy metals)
- In House molecular laboratory (cardiometabolic, hormonal, neurodegenerative biomarkers)
- Neurodegeneration biomarkers (p Tau, neurofilament light)
- C Peptide point Of Care assay
- Personalized health dashboard and bioinformatics platform
- Nutrition intelligence testing
Elsewhere
Profiles
Before You Book
- Physician assignment. Nistrup leads clinical interpretation, but Aetas lists several registered physicians. Confirm who will handle your consult.
- Health Concierge. If you want Nistrup specifically as a senior physician contact, ask whether that is available in the concierge tier.
- Care setting. Clinical work is tied to the Hellerup clinic and Aetas's in-house lab model.
Verification
- Profile updated
- Credentials checked
Primary sourcehttps://aetas.dk/en/about.html
Where a detail is missing, it means we have not verified it—not that the answer is no. Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.